Melanoma: SLN surveillance 'increasing dramatically'

And evaluation of early outcomes following this change in practice reinforces the benefit for patients, researchers say

A real-world study shows major treatment centres across the world are increasingly and successfully using active surveillance rather than surgery to manage sentinel lymph nodes in cutaneous melanoma.

Australia has been an enthusiastic adopter, with patients at three leading centres being the least likely to undergo completion lymph node dissection (CLND) compared with those at 18 other centres in Europe and the US.

The move away from CLND is a response to two pivotal trials (The German Dermatologic Co-operative Oncology Group